High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant.
Shropshire WC, Endres BT, Borjan J, Aitken SL, Bachman WC, McElheny CL, Wu CT, Egge SL, Khan A, Miller WR, Bhatti MM, Saharasbhojane P, Kawai A, Shields RK, Shelburne SA, Doi Y.
Shropshire WC, et al. Among authors: egge sl.
J Antimicrob Chemother. 2023 Oct 3;78(10):2442-2450. doi: 10.1093/jac/dkad249.
J Antimicrob Chemother. 2023.
PMID: 37574665